Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 4KL2TR001077-04 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Funding completion date passed, inadequate enrollment
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institutes of Health (NIH) | NIH |
| University of Nebraska | OTHER |
Not provided
Not provided
Not provided
Not provided
This research is being done to evaluate the feasibility of a prudent versus Western diet feeding study in women with asthma in Baltimore City. The results of this research will provide data to appropriately design a definitive study looking at the differential effects of these two diets on asthma health.
The investigators are interested in the effects of two different diets on asthma health. The first, a prudent diet, consists of a high intake of fruits and vegetables, whole grains, fiber, omega-3 fatty acids, low-fat dairy products, and overall high levels of antioxidants (which may protect the lungs and the body against inflammation in patients with asthma). The second, a Western diet, consists of a high intake of processed foods, fast foods, sweets, omega-6 fatty acids, and a low intake of fiber (which may promote inflammation in the lungs and the body of patients with asthma).
This pilot study will test the feasibility/acceptability of the study design in providing these two diets to participants over a short period of time (6 days per diet), and gather preliminary data on asthma health outcomes that will be used to design a larger, definitive trial. Each participant will be randomly (by chance, like flipping a coin) assigned to start with one of these diets. All foods in each of the diets will be supplied by the study, and participants will be expected to eat all of the food provided and only the food provided for the next 6 days. The investigators will make sure that each participant gets enough food for what their body needs, based on a visit with a nutritionist at the beginning of the study. After eating either the Prudent diet or Western diet for 6 days, participants will have a 4-8 week break (or washout period), during which they will eat their usual diet. Then participants will begin the alternate dietary intervention (Prudent or Western) for another 6 days, depending on which they received first. Before and after each dietary period, researchers will ask questions, check lung function, and collect samples from participants to determine acceptability of the meals and study design, gather feedback on the intervention and overall study structure, assess for changes in lung health and asthma control, measure inflammation and oxidative stress in the lungs and systemic circulation, and evaluate changes in the airway and gut microbiome associated with the interventions that may influence the asthmatic response.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Prudent diet then Western diet | Active Comparator | Participants randomized to this arm will received 6 days of meals consistent with a Prudent diet, followed by a washout period, and then 6 days of meals consistent with a Western diet. |
|
| Western diet then Prudent diet | Active Comparator | Participants randomized to this arm will received 6 days of meals consistent with a Western diet, followed by a washout period, and then 6 days of meals consistent with a Prudent diet. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Prudent diet | Other | Six days of meals provided with high amounts of fruits and vegetables, whole grains, fiber, omega-3 fatty acids, low-fat dairy products, and overall high levels of antioxidants. |
| Measure | Description | Time Frame |
|---|---|---|
| Feasibility: participant feedback | We will measure this via questionnaire at the final study visit. | At conclusion of second feeding period, 7-14 weeks post-enrollment |
| Feasibility: adherence to diet | Daily adherence diaries completed by each participant during each dietary intervention. | Completed daily during each of the two, 6-day feeding periods. |
| Feasibility: serum carotenoids | Serum carotenoids will be measured the morning prior to initiating each feeding period and the morning following completion of each 6-day feeding period. | Difference between day 1 and day 7 of each feeding period |
| Feasibility: serum lipids | Serum lipids will be measured the morning prior to initiating each feeding period and the morning following completion of each 6-day feeding period. | Difference between day 1 and day 7 of each feeding period |
| Feasibility: serum free fatty acids | Serum free fatty acids will be measured the morning prior to initiating each feeding period and the morning following completion of each 6-day feeding period. | Difference between day 1 and day 7 of each feeding period |
| Feasibility: obtaining sputum samples | Induced sputum will be collected for analysis of airway inflammation, a proposed key outcome for a definitive future trial. | Difference between baseline levels and levels on day 7 of each feeding period. |
| Measure | Description | Time Frame |
|---|---|---|
| Asthma Quality of Life Questionnaire (AQLQ) | Asthma Quality of Life Questionnaire (AQLQ) is a 32 item questionnaire and each question uses a 7-point Likert scale (7 = not impaired at all - 1 = severely impaired). | Difference between baseline levels and levels on day 7 of each feeding period. |
| Asthma Symptom Utility Index (ASUI) |
Not provided
Inclusion criteria:
Age 18-55
Female
Obese (BMI>30kg/m2)
Not breastfeeding
Diagnosis of asthma, defined as
Stable asthma, defined by no asthma exacerbation (ED visit, course of increased systemic steroids, or urgent health care visit for asthma) during the prior four weeks.
Symptomatic asthma (Asthma Control Test <20 at baseline screening visit)
Non-smoker, defined by no cigarettes in the past year and a negative urine cotinine
No other major pulmonary disease such as cystic fibrosis or chronic obstructive pulmonary disease
Willing to eat study diet and nothing else for each of the 6 days of controlled feeding
Exclusion criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Emily Brigham, MD, MHS | Johns Hopkins University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Johns Hopkins University | Baltimore | Maryland | 21205 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Aug 10, 2021 | Aug 10, 2021 | Prot_SAP_000.pdf |
Not provided
| ID | Term |
|---|---|
| D001249 | Asthma |
| ID | Term |
|---|---|
| D001982 | Bronchial Diseases |
| D012140 | Respiratory Tract Diseases |
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000072001 | Diet, Healthy |
| D066273 | Diet, Western |
| ID | Term |
|---|---|
| D004032 | Diet |
| D009747 | Nutritional Physiological Phenomena |
| D000066888 | Diet, Food, and Nutrition |
| D010829 | Physiological Phenomena |
Not provided
Not provided
This is a randomized crossover pilot trial to evaluate the feasibility of a Western and prudent diet feeding study in Baltimore City adults with asthma.
Not provided
Not provided
Participants and nutrition staff will be aware of randomization assignments. All other study staff and the investigators will be blinded to assignment during the study.
| Western diet | Other | Six days of meals provided with high amounts of processed foods, fast foods, sweets, omega-6 fatty acids, and a low intake of fiber. |
|
Asthma Symptom Utility Index (ASUI, range 0-1, higher score denoting fewer symptoms) will be measured. |
| Difference between day 1 and day 7 of each feeding period |
| Asthma Control Test (ACT) | Asthma Control Test (ACT, range 5-25, higher score denoting better asthma control). | Difference between baseline levels and levels on day 7 of each feeding period. |
| Daily symptoms | Daily symptom diaries completed by each participant during each dietary intervention. | Completed daily during each of the two, 6-day feeding periods. |
| FEV1 | Spirometry will be measured according to the American Thoracic Society standards. The forced expiratory volume in one second (FEV1) will be assessed. | Difference between day 1 and day 7 of each feeding period |
| FVC | Spirometry will be measured according to the American Thoracic Society standards. The forced vital capacity (FVC) will be assessed. | Difference between day 1 and day 7 of each feeding period |
| FEV1/FVC ratio | Spirometry will be measured according to the American Thoracic Society standards. The forced expiratory volume in one second (FEV1)/forced vital capacity (FVC) ratio will be assessed. | Difference between day 1 and day 7 of each feeding period |
| Albuterol inhaler (rescue medication) use | Daily diaries of self-reported albuterol use completed by each participant during each dietary intervention. | Completed daily during each of the two, 6-day feeding periods. |
| Exhaled nitric oxide | Exhaled nitric oxide is an indicator of airway inflammation and will be measured according to American Thoracic Society standards. | Difference between day 1 and day 7 of each feeding period. |
| Markers of systemic Th2 inflammation | Serum and urine will be assessed for markers of Th2 inflammation. | Difference between day 1 and day 7 of each feeding period. |
| Markers of airway Th2 inflammation | Sputum will be assessed for markers of Th2 inflammation. | Difference between baseline levels and levels on day 7 of each feeding period. |
| Markers of systemic Th1 inflammation | Serum will be assessed for markers of Th1 inflammation. | Difference between day 1 and day 7 of each feeding period. |
| Markers of airway Th1 inflammation | Sputum will be assessed for markers of Th1 inflammation. | Difference between baseline levels and levels on day 7 of each feeding period. |
| Markers of systemic oxidative stress | Serum and urine will be assessed for markers of oxidative stress. | Difference between day 1 and day 7 of each feeding period. |
| Markers of airway oxidative stress | Sputum will be assessed for markers of oxidative stress. | Difference between baseline levels and levels on day 7 of each feeding period. |
| Upper airway microbiome | Microbiome assessment via nasal swab collection. | Difference between microbial community composition on day 1 and day 7 of each feeding period. |
| Lower airway microbiome | Microbiome assessment via sputum collection. | Difference in microbial community composition between baseline and day 7 of each feeding period. |
| Gut microbiome | Microbiome assessment via stool collection. | Difference between microbial community composition on day 1 and day 7 of each feeding period. |
| D012130 |
| Respiratory Hypersensitivity |
| D006969 | Hypersensitivity, Immediate |
| D006967 | Hypersensitivity |
| D007154 | Immune System Diseases |